Agilent ACEA xCELLigence RTCA CardioECR Real-Time Cell Analyzer System Unit 2

The Agilent ACEA xCELLigence RTCA CardioECR System is an advanced real-time cell analyzer designed for comprehensive, label-free monitoring of cardiomyocyte function, combining impedance measurement and field potential electrophysiology detection in a single compact platform. It is widely used in cardiac safety pharmacology, drug discovery, and electrophysiological studies relevant to biotechnology and molecular diagnostics.

Key technical specifications include:

This system performs non-invasive, label-free analysis of cardiomyocyte attachment, viability, contractility, and electrophysiological properties essential to bioprocessing workflows and synthetic biology research focusing on cardiac models. The instrumentation supports acute (seconds to minutes) and long-term (hours to days) assays, enabling high-sensitivity detection of changes in contractility and ionic channel activity. This makes it critical in molecular cloning workflows, cardiovascular toxicology, and biopharmaceutical production pipelines.

The device integrates with RTCA CardioECR trial software and includes complete power and communication cables for streamlined connectivity. Its compact design supports space-conscious laboratories involved in live-cell cardiac assays and electrophysiological screening in clinical diagnostics and biomedical engineering. The system has been fully serviced to ensure operational reliability, with thorough electronic inspection, communication verification, and plate recognition accuracy confirmed.

This instrument is ideal for researchers requiring robust, label-free cardiomyocyte analysis that delivers comprehensive impedance and field potential data, making it a critical asset in cardiac safety and electrophysiological assay development for both academic and industrial biotechnology settings.